Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
{"Image DocumentName": "Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial", "Image ImageDescription": "Christopher M Nutting, James P Morden, Kevin J Harrington, Teresa Guerrero Urbano, Shreerang A Bhide, Catharine Clark, Elizabeth A Miles, Aisha B Miah, Kate Newbold, MaryAnne Tanay, Fawsi Adab, Sarah J Jeffer ies, Christopher Scrase, Beng K Yap, Roger P A\u2019Hern, Mark A Sydenham, Marie Emson, Emma Hall, on behalf of the PARSPORT trial management group. Lancet Oncology 2011; 12:", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}